Mkt Cap$2.31T+0.21%
24h Vol$69.08B
BTC Dom56.2%
ETH Dom10.0%
F&G25Extreme Fear
BTC$64,896.00+0.03% ETH$1,923.97+2.07% USDT$0.9994+0.01% BNB$580.73-0.15% USDC$0.99990.00% XRP$1.12+0.43% SOL$77.50-0.35% TRX$0.3245-0.41% FIGR_HELOC$1.04+0.05% HYPE$67.03+1.75% DOGE$0.074-0.52% USDS$0.9999+0.01% ZEC$576.61+2.76% RAIN$0.0146-2.25% LEO$9.81+1.14% WBT$56.90+0.35% BTC$64,896.00+0.03% ETH$1,923.97+2.07% USDT$0.9994+0.01% BNB$580.73-0.15% USDC$0.99990.00% XRP$1.12+0.43% SOL$77.50-0.35% TRX$0.3245-0.41% FIGR_HELOC$1.04+0.05% HYPE$67.03+1.75% DOGE$0.074-0.52% USDS$0.9999+0.01% ZEC$576.61+2.76% RAIN$0.0146-2.25% LEO$9.81+1.14% WBT$56.90+0.35%
News

Earnings

Total Stories
1,193
Section
Earnings
Legend Biotech (LEGN) Shows Strong Q3 Performance Despite Revenue Shortfall
Earnings

Legend Biotech (LEGN) Shows Strong Q3 Performance Despite Revenue Shortfall

Legend Biotech posted Q3 2025 EPS of -$0.11 and revenue of $272.33 million, supported by strong demand for CARVYKTI®.

Tim FriesNov 12, 20253 min read